Client-Level Coverage of Needle and Syringe Program and High-Risk Injection Behaviors: A Case Study of People Who Inject Drugs in Kermanshah, Iran
Needle-syringe programs (NSP) have been running in Iran since 2002. However, the coverage of such program among the NSP clients at the individual level was not studies yet. This study aimed to determine the client coverage of NSP and its correlation with high injection-related risk behaviors. A cros...
Saved in:
Published in: | Addiction and health Vol. 7; no. 3-4; pp. 164 - 173 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Iran
Kerman University of Medical Sciences
01-01-2015
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Needle-syringe programs (NSP) have been running in Iran since 2002. However, the coverage of such program among the NSP clients at the individual level was not studies yet. This study aimed to determine the client coverage of NSP and its correlation with high injection-related risk behaviors.
A cross-sectional survey was conducted in Kermanshah province, Iran, in 2014. 230 people who inject drugs (PWID) recruited from two drop-in centers (DICs) from April to September 2014, participated in a face-to-face interview to provide information related individual coverage of NSP, demographic characteristics, and injecting behaviors 30 days prior to the interview.
Overall, the average of syringe coverage was 158% [95% confidence interval (CI) = 65.7-205.5], while 56% (95% CI = 40-97) have individual converge less than 100%. Needle/syringe sharing was significantly higher among individual with low NSP coverage [adjusted odds ratio (AOR) = 2.6, 95% CI = 1.3-6.2]. About 85% participants with coverage of less than 100% reported reuse of syringe within the last 30 days (AOR = 3.2, 95% CI = 1.4-7.7).
PWID are different regarding their NSP individual-level converges. There are certain clusters of PWID, who do not receive sufficient number of syringes. Given that insufficient individual syringe coverage level is highly associated with injection risk behaviors, reasons for such low converge need to be assessed and addressed carefully. |
---|---|
AbstractList | BACKGROUNDNeedle-syringe programs (NSP) have been running in Iran since 2002. However, the coverage of such program among the NSP clients at the individual level was not studies yet. This study aimed to determine the client coverage of NSP and its correlation with high injection-related risk behaviors. METHODSA cross-sectional survey was conducted in Kermanshah province, Iran, in 2014. 230 people who inject drugs (PWID) recruited from two drop-in centers (DICs) from April to September 2014, participated in a face-to-face interview to provide information related individual coverage of NSP, demographic characteristics, and injecting behaviors 30 days prior to the interview. FINDINGSOverall, the average of syringe coverage was 158% [95% confidence interval (CI) = 65.7-205.5], while 56% (95% CI = 40-97) have individual converge less than 100%. Needle/syringe sharing was significantly higher among individual with low NSP coverage [adjusted odds ratio (AOR) = 2.6, 95% CI = 1.3-6.2]. About 85% participants with coverage of less than 100% reported reuse of syringe within the last 30 days (AOR = 3.2, 95% CI = 1.4-7.7). CONCLUSIONPWID are different regarding their NSP individual-level converges. There are certain clusters of PWID, who do not receive sufficient number of syringes. Given that insufficient individual syringe coverage level is highly associated with injection risk behaviors, reasons for such low converge need to be assessed and addressed carefully. Needle-syringe programs (NSP) have been running in Iran since 2002. However, the coverage of such program among the NSP clients at the individual level was not studies yet. This study aimed to determine the client coverage of NSP and its correlation with high injection-related risk behaviors. A cross-sectional survey was conducted in Kermanshah province, Iran, in 2014. 230 people who inject drugs (PWID) recruited from two drop-in centers (DICs) from April to September 2014, participated in a face-to-face interview to provide information related individual coverage of NSP, demographic characteristics, and injecting behaviors 30 days prior to the interview. Overall, the average of syringe coverage was 158% [95% confidence interval (CI) = 65.7-205.5], while 56% (95% CI = 40-97) have individual converge less than 100%. Needle/syringe sharing was significantly higher among individual with low NSP coverage [adjusted odds ratio (AOR) = 2.6, 95% CI = 1.3-6.2]. About 85% participants with coverage of less than 100% reported reuse of syringe within the last 30 days (AOR = 3.2, 95% CI = 1.4-7.7). PWID are different regarding their NSP individual-level converges. There are certain clusters of PWID, who do not receive sufficient number of syringes. Given that insufficient individual syringe coverage level is highly associated with injection risk behaviors, reasons for such low converge need to be assessed and addressed carefully. Background: Needle-syringe programs (NSP) have been running in Iran since 2002. However, the coverage of such program among the NSP clients at the individual level was not studies yet. This study aimed to determine the client coverage of NSP and its correlation with high injection-related risk behaviors. Methods: A cross-sectional survey was conducted in Kermanshah province, Iran, in 2014. 230 people who inject drugs (PWID) recruited from two drop-in centers (DICs) from April to September 2014, participated in a face-to-face interview to provide information related individual coverage of NSP, demographic characteristics, and injecting behaviors 30 days prior to the interview. Findings: Overall, the average of syringe coverage was 158% [95% confidence interval (CI) = 65.7-205.5], while 56% (95% CI = 40-97) have individual converge less than 100%. Needle/syringe sharing was significantly higher among individual with low NSP coverage [adjusted odds ratio (AOR) = 2.6, 95% CI = 1.3-6.2]. About 85% participants with coverage of less than 100% reported reuse of syringe within the last 30 days (AOR = 3.2, 95% CI = 1.4-7.7). Conclusion: PWID are different regarding their NSP individual-level converges. There are certain clusters of PWID, who do not receive sufficient number of syringes. Given that insufficient individual syringe coverage level is highly associated with injection risk behaviors, reasons for such low converge need to be assessed and addressed carefully. |
Author | Zamani, Saman Soori, Hamid Higgs, Peter Noroozi, Mehdi Noroozi, Alireza Mirzazadeh, Ali Mehrabi, Yadoallah Hajebi, Ahmad Sharifi, Hamid |
AuthorAffiliation | 4 Professor, Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran 6 Assistant Professor, Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland 7 Assistant Professor, Regional Knowledge Hub and WHO Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran 5 Associate Professor, Mental Health Research Center and Department of Community Psychiatry, School of Behavioral Sciences and Mental Health, Tehran Institute of Psychiatry, Iran University of Medical Sciences, Tehran, Iran 8 Senior Fellow, National Drug Research Institute, Faculty of Health Sciences, Curtin University, Melbourne, Australia 3 Psychiatrist, Iranian National Center for Addiction Studies (INCAS), Iranian Institute for Reduction of High-Risk Behaviors AND School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran 9 Professor, Safety Pro |
AuthorAffiliation_xml | – name: 6 Assistant Professor, Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland – name: 5 Associate Professor, Mental Health Research Center and Department of Community Psychiatry, School of Behavioral Sciences and Mental Health, Tehran Institute of Psychiatry, Iran University of Medical Sciences, Tehran, Iran – name: 2 Assistant Professor, Global Health Sciences, University of California, San Francisco, CA, USA AND Regional Knowledge Hub and WHO Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran – name: 3 Psychiatrist, Iranian National Center for Addiction Studies (INCAS), Iranian Institute for Reduction of High-Risk Behaviors AND School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran – name: 9 Professor, Safety Promotion and Injury Prevention Research Center AND Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran – name: 4 Professor, Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran – name: 8 Senior Fellow, National Drug Research Institute, Faculty of Health Sciences, Curtin University, Melbourne, Australia – name: 1 PhD Candidate, Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran – name: 7 Assistant Professor, Regional Knowledge Hub and WHO Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran |
Author_xml | – sequence: 1 givenname: Mehdi surname: Noroozi fullname: Noroozi, Mehdi organization: PhD Candidate, Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 2 givenname: Ali surname: Mirzazadeh fullname: Mirzazadeh, Ali organization: Assistant Professor, Global Health Sciences, University of California, San Francisco, CA, USA AND Regional Knowledge Hub and WHO Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran – sequence: 3 givenname: Alireza surname: Noroozi fullname: Noroozi, Alireza organization: Psychiatrist, Iranian National Center for Addiction Studies (INCAS), Iranian Institute for Reduction of High-Risk Behaviors AND School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran – sequence: 4 givenname: Yadoallah surname: Mehrabi fullname: Mehrabi, Yadoallah organization: Professor, Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 5 givenname: Ahmad surname: Hajebi fullname: Hajebi, Ahmad organization: Associate Professor, Mental Health Research Center and Department of Community Psychiatry, School of Behavioral Sciences and Mental Health, Tehran Institute of Psychiatry, Iran University of Medical Sciences, Tehran, Iran – sequence: 6 givenname: Saman surname: Zamani fullname: Zamani, Saman organization: Assistant Professor, Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland – sequence: 7 givenname: Hamid surname: Sharifi fullname: Sharifi, Hamid organization: Assistant Professor, Regional Knowledge Hub and WHO Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran – sequence: 8 givenname: Peter surname: Higgs fullname: Higgs, Peter organization: Senior Fellow, National Drug Research Institute, Faculty of Health Sciences, Curtin University, Melbourne, Australia – sequence: 9 givenname: Hamid surname: Soori fullname: Soori, Hamid organization: Professor, Safety Promotion and Injury Prevention Research Center AND Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26885353$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkd1u1DAQhSPUipbSV0C-5IJIcez4hwukEn66YgUVbcVlNIkniZfE3trJSvsaPDFpu0V0bmZ05ug70syr5Mh5hy-S0zzLVKq40EeHmQvGTpLzGDfZUqKgPOcvk5NcKFWwgp0mf8rBopvSNe5wIKXfYYAOiW_Jd0QzIAFnyPU-WLeoV8F3AcYH7dJ2ffrTxt9k5TbYTNY78hF72Fkf4ntyQUqISK6n2ezvaVfotwvtV-8PfvIpzF0k1pFvGEZwsYf-HVkFcK-T4xaGiOeHfpbcfvl8U16m6x9fV-XFOjVUSpnWNWheU9BUtNAIbbRRLBOS5Y3iXDPNjRC0VYYrxinXtGayMKoWnJqMZpSdJatHrvGwqbbBjhD2lQdbPQg-dBWEyTYDVrwpal0gqsw03FAOWgJFmWsApLlsF9aHR9Z2rkc0zXLSAMMz6PONs33V-V3FJac5kwvg7QEQ_N2McapGGxscBnDo51hRKUQuBFf31jf_Z_0LeXoq-wsyWKER |
ContentType | Journal Article |
Copyright | 2015 Kerman University of Medical Sciences 2015 |
Copyright_xml | – notice: 2015 Kerman University of Medical Sciences 2015 |
DBID | NPM 7X8 5PM DOA |
DatabaseName | PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2008-8469 |
EndPage | 173 |
ExternalDocumentID | oai_doaj_org_article_4c5b95ee80dc4d14a97a1e729aae127f 26885353 |
Genre | Journal Article |
GroupedDBID | ABDBF ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL C1A DIK EAP EOJEC ESX GROUPED_DOAJ HYE KQ8 KWQ M48 M~E NPM OBODZ OK1 PGMZT RNS RPM 7X8 5PM |
ID | FETCH-LOGICAL-d1777-bba94b1a916fac69d9d8306732c8449394d661f8d48341491b375d8b641d01013 |
IEDL.DBID | RPM |
ISSN | 2008-4633 |
IngestDate | Tue Oct 22 15:13:08 EDT 2024 Tue Sep 17 20:53:52 EDT 2024 Fri Aug 16 10:33:44 EDT 2024 Sat Sep 28 07:57:40 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3-4 |
Keywords | Risk behaviors Effectiveness Needle-syringe programs Iran Individual-coverage |
Language | English |
License | This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-d1777-bba94b1a916fac69d9d8306732c8449394d661f8d48341491b375d8b641d01013 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741237/ |
PMID | 26885353 |
PQID | 1766266487 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_4c5b95ee80dc4d14a97a1e729aae127f pubmedcentral_primary_oai_pubmedcentral_nih_gov_4741237 proquest_miscellaneous_1766266487 pubmed_primary_26885353 |
PublicationCentury | 2000 |
PublicationDate | 20150101 |
PublicationDateYYYYMMDD | 2015-01-01 |
PublicationDate_xml | – month: 1 year: 2015 text: 20150101 day: 1 |
PublicationDecade | 2010 |
PublicationPlace | Iran |
PublicationPlace_xml | – name: Iran |
PublicationTitle | Addiction and health |
PublicationTitleAlternate | Addict Health |
PublicationYear | 2015 |
Publisher | Kerman University of Medical Sciences |
Publisher_xml | – name: Kerman University of Medical Sciences |
References | 16980914 - J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):335-43 18038459 - Drug Alcohol Depend. 2007 Dec 1;91(2-3):300-5 17286637 - Addiction. 2007 Apr;102(4):638-46 23241516 - J Res Health Sci. 2012 Dec 13;12(2):81-7 17565564 - Addiction. 2007 Aug;102(8):1244-50 20208066 - J Public Health (Oxf). 2010 Sep;32(3):328-35 11128265 - Soc Sci Med. 2000 Dec;51(12):1771-82 16212655 - Harm Reduct J. 2005 Oct 07;2:19 17689351 - Int J Drug Policy. 2007 Mar;18(2):92-8 9813900 - Addiction. 1998 Aug;93(8):1191-7 18313910 - Int J Drug Policy. 2008 Apr;19 Suppl 1:S25-36 9632987 - AIDS. 1998;12 Suppl A:S71-9 10780722 - AIDS. 2000 Mar 31;14(5):605-11 11078115 - Eur J Epidemiol. 2000;16(7):601-6 9722822 - Public Health Rep. 1998 Jun;113 Suppl 1:170-81 17280802 - Drug Alcohol Depend. 2007 Jul 10;89(2-3):214-22 15821397 - AIDS. 2005 Apr 29;19(7):709-16 22071120 - Drug Alcohol Depend. 2012 May 1;122(3):195-200 22000694 - Int J Drug Policy. 2012 Jul;23(4):271-8 18483849 - AIDS Behav. 2010 Aug;14(4):885-90 10877496 - J Acquir Immune Defic Syndr. 2000 May 1;24(1):57-61 24064986 - Sex Transm Infect. 2013 Nov;89 Suppl 3:iii41-4 24037249 - Sex Transm Infect. 2013 Nov;89 Suppl 3:iii29-32 18641473 - AIDS. 2008 Aug;22 Suppl 2:S81-92 8555955 - Addiction. 1995 Dec;90(12):1635-45 |
References_xml | |
SSID | ssj0000651424 |
Score | 1.9481432 |
Snippet | Needle-syringe programs (NSP) have been running in Iran since 2002. However, the coverage of such program among the NSP clients at the individual level was not... BACKGROUNDNeedle-syringe programs (NSP) have been running in Iran since 2002. However, the coverage of such program among the NSP clients at the individual... Background: Needle-syringe programs (NSP) have been running in Iran since 2002. However, the coverage of such program among the NSP clients at the individual... |
SourceID | doaj pubmedcentral proquest pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 164 |
SubjectTerms | effectiveness individual-coverage iran needle-syringe programs Original risk behaviors |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWgJy4IxNdSQIPEkYjYceKYW9m2agWqKgqCW-RPdqHyVhv20Bu_gDO_j1_SGXtbdRESF65OZFsea-aN_fyGsRfOdN64pq6ciE0lo3CVxRyssr7rg3U2iECPkw9O1NHnfnePZHKuSn0RJ6zIA5eFeyVda3UbQl97Jz2XRivDA0JCYwIXKmbvW3fXkqnig1t6wkWV5eh-X3ZUGDeL8v8NSf5JiLwWYfbvsNtraAg7ZUp32Y2Q7rFf01N6sVi9I3IPTIlwiR4AFhGOMO6cBjDJw8l5Pp2D40K2ym1E4Kjez8dv8PvHz8P0NVOuEqz1EJfja9iBKYYwICbhOXV4nMnk8Gm2gPI_7C5XX0aYJ-riLbnwNM7M7CUcYoC7zz7u732YHlTragqV50rh6lujpeUG8WA0rtNe-57yhUa4XkrdaOkxVsfe0_Ei5k3cNqr1ve0k9yRE1zxgW2mRwiMGSsXoNQIhLriMWhq0TO2051FoV9t6wt7QUg9nRTBjIAnr3ICGHdaGHf5l2Al7fmmoAbc83WOYFBarcSBNS8QVmGpN2MNiuKuhRNcjAGmbCVMbJt2Yy-aXNJ9lWW2J4Eo06vH_mPw2u4XIqi1nNU_Y1vflKjxlN0e_epY36gX7sPOM priority: 102 providerName: Directory of Open Access Journals |
Title | Client-Level Coverage of Needle and Syringe Program and High-Risk Injection Behaviors: A Case Study of People Who Inject Drugs in Kermanshah, Iran |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26885353 https://search.proquest.com/docview/1766266487 https://pubmed.ncbi.nlm.nih.gov/PMC4741237 https://doaj.org/article/4c5b95ee80dc4d14a97a1e729aae127f |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbYnrggEK_lURmJI-nGjhPH3EraqhVQrSgIbpGf3YWtU23YQ_8Gv5gZJ4u6iBNXJ04sz2ge9jffEPLa6sppW-SZ5aHIROA2M5CDZcZVtTfWeO6xOPn0Qp5_q4-OkSan3NbCJNC-NcuDuLo6iMtFwlZeX9nZFic2m39sBLhBXsjZhEwgNryVog_mt8TqLWwqh1f7oiqwVw6vanBM2AI5UfP_K578GxZ5y8-c3Cf3xgCRHg4LeUDu-PiQ_GpWWLeYfUCID20Qdgl2gHaBnoP3WXmqo6MXN-mMjs4HyFUaQxhH9mnZ_6Bn8XtCXUU6UiKu-7f0kDbgxSiCCW_wa_OEJ6dfF934Pj1aby57uoz0PZrw2C_04g09Awf3iHw5Of7cnGZjN4XMMSlh941WwjAN8WDQtlJOuRrzhYLbWghVKOHAV4fa4fEi5E3MFLJ0takEc0hEVzwme7GL_imhUobgFARCjDMRlNBWuNwqxwJXNjf5lLzDTW6vB8KMFims00C3vmxHQbbClkaV3te5g-lMaCU18yBPrT3jMkzJq62IWlB5vMfQ0XebvkVOS4grINWakieDyP78aivnKZE7wtxZy-4T0LJEqz1q1bP_nvmc3IVwqhwOaF6QvZ_rjX9JJr3b7KdUfz8p6m-P6PA9 |
link.rule.ids | 230,315,729,782,786,887,2106,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZoOcCFh3hty8NIHEk3Tpw45lbSVrvqdrWiRXCL_Ep3YetUG_bQv8EvZsbJoi7i1KsdJ1bG9jz8zTeEfDAqt8qkcWSSOo14nZhIgw8WaZsXThvtEofJyaNzMf1eHB0jTU62yYUJoH2jFwd-eXXgF_OArby-MsMNTmw4Oys5qMEkFcMdch_2axzfctK7AzjD_C0sK4eX-zxPsVpOkhegmrAIciDn_59F-S8w8pamOXl8xzk-IY9605Iedt1PyT3nn5Hf5RIzHqMJgoNoiYBNOEFoU9Mp6K2lo8pben4Tont01oG1QhsCQKIvi_YnHfsfAa_laU-muGo_0UNagv6jCEO8wbfNAhKdfps3_fP0aLW-bOnC01M8_H07V_OPdAyq8Tn5enJ8UY6ivg5DZJkQIDetJNdMgSVZK5NLK22BnkaamIJzmUpuQcvXhcXAJHhcTKcis4XOObNIYZe-ILu-8e4VoULUtZVgQrGE8VpyZbiNjbSsTqSJdTwgn1E41XVHtVEh-XVoaFaXVf97K24yLTPnitjCcMaVFIo58BKUciwR9YC834i2gs2CNyDKu2bdVsiGCRYJOGkD8rIT9d9PbdbHgIitRbA1l-0ekH0g5O5lvXfnke_Ig9HF2aSajKen--QhGGVZF-Z5TXZ_rdbuDdlp7fptWOZ_AN4XBNs |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLbYkBAvXMRl5WokHskaO04c8zbSVas2qoqB4C3ydS10TtXQh_0NfjE-TjqtiCd4dezEyrH9nWN__g5Cb7UsjNRZmmjqsoQ5qhMVYrBEmaK0SitLLVxOPjnn02_l6Bhkcq5TfUXSvlaLQ7-8PPSLeeRWri71cMsTG84-VizAIM34cGXccA_dDnM2pTcC9W4RzuEOF6SWgwN-VmSQMYcWZYAnSIQcBfr_5lX-SY68gTbj-__RzwfoXu9i4qOuykN0y_pH6Fe1hJuPyRmQhHAFxM2wkuDG4WnAr6XF0ht8fhV3-fCsI23FMiCCJJ8W7Q888d8jb8vjXlRx3b7HR7gKOIiBjngFb5tFRjr-Om_6-ni03ly0eOHxKYCAb-dy_g5PAkQ-Rl_Gx5-rk6TPx5AYwnmwn5KCKSKDR-mkLoQRpoSII6O6ZExkgpmA9q40sEEZIi-iMp6bUhWMGJCyy56gfd94e4Aw584ZEVwpQglzgknNTKqFIY4Knap0gD6AgepVJ7lRgwh2LGjWF3X_i2umcyVya8vUhOaEScElsSFakNISyt0Avdmatw6TBk5CpLfNpq1BFTN4JiFYG6CnnbmvP7UdIwPEdwbCTl92nwT7R2Hu3t7P_rnla3RnNhrXZ5Pp6XN0N_hmebfb8wLt_1xv7Eu015rNqzjSfwMOvQdb |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Client-Level+Coverage+of+Needle+and+Syringe+Program+and+High-Risk+Injection+Behaviors%3A+A+Case+Study+of+People+Who+Inject+Drugs+in+Kermanshah%2C+Iran&rft.jtitle=Addiction+and+health&rft.au=Noroozi%2C+Mehdi&rft.au=Mirzazadeh%2C+Ali&rft.au=Noroozi%2C+Alireza&rft.au=Mehrabi%2C+Yadoallah&rft.date=2015-01-01&rft.issn=2008-4633&rft.volume=7&rft.issue=3-4&rft.spage=164&rft.epage=173&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2008-4633&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2008-4633&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2008-4633&client=summon |